HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of FACIT collagens XII and XIV during bleomycin-induced pulmonary fibrosis in mice.

Abstract
Collagens XII and XIV are members of a subfamily of fibril-associated collagens with interrupted triple-helices (FACITs) that facilitate the interactions of adjacent collagen fibrils. Using immunohistochemistry and in situ hybridization, we analyzed the spatial and temporal expression pattern of collagens XII and XIV during bleomycin-induced pulmonary fibrosis. C57Bl mice were treated with bleomycin (1 U, i.p., every other day for 8 days) or saline (control), and lung tissue samples were analyzed 2-12 weeks later. Collagen I protein expression was increased in the lung 2 weeks post bleomycin treatment and persisted for at least 12 weeks. In contrast, collagen XII and XIV expression was low until 4 weeks after bleomycin treatment. Whereas collagen XII expression was greatest between 4 weeks and 8 weeks, expression of collagen XIV persisted from 4 to 12 weeks, which suggests that these two proteins may play distinct roles in the fibrotic process. The mRNA for lysyl oxidase (LOX), an enzyme for cross-linking of collagens, had a delayed increase in the lung after bleomycin administration. It reached a maximum after 8 weeks, and persisted throughout the 12 weeks of the study. These data support the hypothesis that fibrosis is a multistep process that involves both collagen accumulation and changes in the molecules that modulate the biomechanical properties of fibrils.
AuthorsEleni G Tzortzaki, Jay A Tischfield, Amrik Sahota, Nikolaos M Siafakas, Marion K Gordon, Donald R Gerecke
JournalThe anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology (Anat Rec A Discov Mol Cell Evol Biol) Vol. 275 Issue 2 Pg. 1073-80 (Dec 2003) ISSN: 1552-4884 [Print] United States
PMID14613307 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
CopyrightCopyright 2003 Wiley-Liss, Inc.
Chemical References
  • Antimetabolites, Antineoplastic
  • COL14A1 protein, human
  • Col14a1 protein, mouse
  • Collagen Type I
  • Collagen Type XII
  • Fibril-Associated Collagens
  • Glycoproteins
  • RNA, Messenger
  • Bleomycin
  • Collagen
  • Protein-Lysine 6-Oxidase
Topics
  • Animals
  • Antimetabolites, Antineoplastic (administration & dosage, adverse effects)
  • Bleomycin (administration & dosage, adverse effects)
  • Collagen (metabolism)
  • Collagen Type I (metabolism)
  • Collagen Type XII (metabolism)
  • Female
  • Fibril-Associated Collagens (metabolism)
  • Gene Expression Regulation
  • Gene Expression Regulation, Enzymologic
  • Glycoproteins (metabolism)
  • Immunohistochemistry
  • In Situ Hybridization
  • Lung (metabolism, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Protein-Lysine 6-Oxidase (analysis)
  • Pulmonary Fibrosis (chemically induced, metabolism)
  • RNA, Messenger (analysis)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: